Cannabigerol (1.0 mg/mL in Methanol)

• CAT Number: R064301
• CAS Number: 25654-31-3
• Molecular Formula: C21H32O2
• Molecular Weight: 316.48
• Purity: ≥95%
• Synonyms: 2-[(2E)-3,7-Dimethyl-2,6-octadien-1-yl]-5-pentyl-1,3-benzenediol; (E)-2-(3,7-Dimethyl-2,6-octadienyl)-5-pentyl-1,3-benzenediol; 2-[(2E)-3,7-Dimethyl-2,6-octadienyl]-5-pentyl-1,3-benzenediol; (E)-2-(3,7-Dimethyl-2,6-octadienyl)-5-pentylresorcinol
• IUPAC Name: 2-[(2E)-3,7-dimethylocta-2,6-dienyl]-5-pentylbenzene-1,3-diol
• InChI: InChI=1S/C21H32O2/c1-5-6-7-11-18-14-20(22)19(21(23)15-18)13-12-17(4)10-8-9-16(2)3/h9,12,14-15,22-23H,5-8,10-11,13H2,1-4H3/b17-12+
• InChIKey: QXACEHWTBCFNSA-SFQUDFHCSA-N
• SMILES: CCCCCC1=CC(=C(C(=C1)O)CC=C(C)CCC=C(C)C)O

Cannabigerol (CAT: R064301) is a non-psychoactive cannabinoid naturally found in Cannabis sativa, often referred to as the “mother cannabinoid” because it serves as the biosynthetic precursor to THC, CBD, and other cannabinoids. CBG interacts with the endocannabinoid system, showing affinity for both CB1 and CB2 receptors, and exhibits potential therapeutic properties including anti-inflammatory, neuroprotective, antibacterial, and analgesic effects. It is being actively researched for applications in treating glaucoma, inflammatory bowel disease, and neurodegenerative conditions.